Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fox Corp Class A (FOXA) vs Nuvalent Inc (NUVL) Price & Performance

Fox Corp Class ATrade
Nuvalent IncTrade

Price performance (Past 24H)

Key statistics

Fox Corp Class A vs Nuvalent Inc — how do they compare? Fox Corp Class A trades at $56.61 (market cap $22.28B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Fox Corp Class A is far larger — about 2.3× Nuvalent Inc's market cap, and Fox Corp Class A pays a 1% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.

FOXANUVL
Market Cap
$22.28B$9.81B
Sector
MediaTechnology
52-Week High
$76.11$123.96
52-Week Low
$48.79$72.16
Enterprise Value
$26.25B$8.52B
Dividend Yield
1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fox Corp Class A

Fox Corporation (FOXA) trades at $55.94, up 1.95% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 14.73 and net income margin of 10.56%, supported by $3.32B in operating cash flow for 2025. Recent news highlights the strategic $22B Roku acquisition, positioning Fox in the competitive streaming landscape.

The outlook is mixed: analyst consensus targets $67.80 (21% upside) with equal buy/hold ratings, but technicals and 2026 cash flow projections signal caution. Key risks include integration challenges from the Roku deal and advertising market volatility. The stock presents a value opportunity if execution risks are managed.

Nuvalent Inc

Nuvalent (NUVL) trades at $123.96, unchanged on the day, amid a pending $124 per share acquisition by GSK. The stock shows a bullish technical signal with moving averages supporting upside, though RSI levels suggest overbought conditions. Fundamentally, the company remains unprofitable with negative ROE and ROA, while cash flow is sustained by financing activities. Recent news is dominated by merger investigations and strategic rationale for the GSK deal.

The investment outlook hinges on the acquisition closing at $124, offering limited upside from current levels. Risks include shareholder litigation and regulatory scrutiny, but the deal provides a clear exit amid ongoing losses. Analyst sentiment is mixed with a slight hold bias, reflecting uncertainty around deal completion and fairness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Fox Corp Class A

Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.

Read more on FOXA

About Nuvalent Inc

Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.

Read more on NUVL